RxDoctor Payments Data

John Lee, MD

Clinical Cardiac Electrophysiology · Lexington, KYNPI 1033521174

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (46.3%), food and beverage and grants — rather than concentrated in one kind of arrangement. 35 manufacturers reported payments, led by Abbott at 33.1% of the total. 2025 is the largest year on record at $36,404, 4.7 times the $7,734 reported in 2019. Among clinical cardiac electrophysiology clinicians in KY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$139,244in general payments, 2019–2025

Across 826 payments — averaging $168.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$46K
  • Medtronic$31K
  • Biotronik Inc.$31K
  • Boston Scientific$21K
  • Philips North America LLC$2K
  • Medical Device Business Services, Inc.$2K
  • plus $6K from 29 others

What the payments were for

  • Consulting fees$14,40310%
  • Speaking & faculty fees$5,3754%
  • Grants$19,50014%
  • Travel & lodging$64,53146%
  • Food & beverage$33,24724%
  • Education$2,1012%
  • Entertainment$870%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$139,244 in reported general payments places this provider in the 90th percentile of 57 clinical cardiac electrophysiology providers in Kentucky.

See all clinical cardiac electrophysiology providers in Kentucky

Medicare billing

Part B allowed, 2024
$260,367
Medicare patients
822
Services billed
2,679

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban91$75,863
XareltoRivaroxaban18$15,866
Flecainide Acetate49$2,342
Amiodarone Hcl58$706
Metoprolol Succinate61$703
ClopidogrelClopidogrel Bisulfate50$496
Metoprolol Tartrate38$280
Carvedilol20$80
Prednisone12$14

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$464$75,86391 claims
Johnson & JohnsonXarelto$14$15,86618 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 57 clinical cardiac electrophysiology providers in Kentucky.

Other clinical cardiac electrophysiology in Lexington

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →